Target- |
Mechanism- |
|
Originator Org.- |
|
Inactive Indication- |
Drug Highest PhasePhase 3 |
First Approval Ctry. / Loc.- |
First Approval Date- |
童喘清颗粒治疗儿童支气管哮喘评价其有效性和安全性的随机双盲、安慰剂平行对照、多中心临床试验
[Translation] A randomized, double-blind, placebo-controlled, multicenter clinical trial to evaluate the efficacy and safety of Tongchuanqing granules in the treatment of childhood bronchial asthma
1.评价童喘清颗粒对于儿童支气管哮喘慢性持续期症状的缓解作用和虚哮证候改善作用。2.评价童喘清颗粒的安全性
[Translation] 1. To evaluate the effect of Tongchuanqing Granules on relieving symptoms of chronic persistent bronchial asthma in children and improving asthma syndrome. 2. To evaluate the safety of Tongchuanqing Granules
100 Clinical Results associated with Nanjing Kailai Pharmaceutical Technology Development Co., Ltd.
0 Patents (Medical) associated with Nanjing Kailai Pharmaceutical Technology Development Co., Ltd.
100 Deals associated with Nanjing Kailai Pharmaceutical Technology Development Co., Ltd.
100 Translational Medicine associated with Nanjing Kailai Pharmaceutical Technology Development Co., Ltd.